Posted on Friday, 3rd December 2010 by Jesse Walker

MUMBAI -(Dow Jones)- India’s Sun Pharmaceuticals Ltd. (524715.BY) said Saturday it had launched an offer to buyout minority shareholders of its unit Caraco Pharmaceutical Laboratories Inc. (CPD), in a bid to delist Caraco.

The drug maker said that it had offered to pay $4.75 per share in cash in a notification to the Bombay Stock Exchange.

Caraco declared a loss in the July-to-September period, and has been facing regulatory problems over the last year, hurting Sun Pharmaceutical’s U.S. sales.

Similar Posts:

Share

Tags: Caraco Pharma, Pharma, Unit Caraco, Unit Caraco Pharma
Posted in Business Investing | Comments (0)

Leave a Reply